
3T Biosciences Stock
3T Biosciences
Sign up today and learn more about 3T Biosciences Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About 3T Biosciences Stock
Investors
Funding History
February 2017 | $0 |
---|
Press
loom - Jan, 10 2023
Boehringer offers 3T Biosciences $268M to plug its data into biotech's TCR cancer platformlife-sciences-europe - Jan, 10 2023
Boehringer–3T Biosciences: cancer immunotherapies, 202301– strategic collab + license agreem RnD of cancer therapies using 3T-TRACE discovery platformbiospace - Aug, 25 2022
3T Biosciences Launches $40M at Solid Tumors with TCR TechEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase